Renaissance Capital logo

VKTX News

US IPO Weekly Recap: 4 IPOs offer dividends and drugs

BPMC

Yield IPOs yielded disappointing returns while biotech performance was anemic. 13 companies were added to the IPO calendar - including 7 in the health care sector - making this an inopportune week for a drop in the NASDAQ Composite. 49 companies have gone public in 2015, and average year-to-date...read more

What's hip in the IPO market: Viking Therapeutics prices upsized IPO at $8 midpoint

VKTX

Viking Therapeutics, which is developing drugs to speed hip fracture recovery and treat various metabolic disorders, raised $24 million by offering 3 million shares at $8, within the range of $7 to $9. It previously expected to raise $20 million by offering 2.5 million shares. The biotech now commands a market value of $73 million. It originally set terms to raise $55 million...read more

Week ahead: 6 IPOs planned for the week of Apr 27

BSM

Up to six companies could price their IPOs this week. All are either LPs or health care companies (including three biotechs). Two LPs on deck, one offering power-generating wood pellets Enviva Partners LP (EVA) is backed by Riverstone/Carlyle and is the world’s largest...read more

Week ahead: 3 IPOs planned for the week of April 20

NSA

This week the IPO market could see a high-yield REIT, a high-growth software provider and a small biotech. After strong performance from ...read more